Individuals Discontinuing Weight-Loss Injections Gain Back Weight Four Times Faster Compared to Those on Conventional Diets

New research suggests that people who discontinue blockbuster slimming jabs like semaglutide or tirzepatide can put back on shed pounds far faster than those who stop traditional lifestyle plans.

Research printed in a leading health publication shows that while obese individuals frequently drop substantial amounts of their body weight while undergoing treatment, the mass returns at an average rate of nearly a kilo each month after stopping.

"People buying these medications should be cognizant of the risk of quick rebound weight gain when the treatment concludes," warns lead investigator Dr. Susan Jebb.

This pace of regain suggests a return to pre-treatment mass in about 18 months.

Analyzing Treatments

The study, which examined dozens of studies involving thousands of patients, contrasted the effects of the injectable medications with conventional dieting.

Researchers emphasize that individuals who lose weight through diet and exercise typically see a slower creep back—perhaps 0.1 kg a month—post-intervention.

The Reason for the Fast Rebound

Doctors believe the way of the jabs accounts for the accelerated regain.

The injections imitate a natural hormone called glucagon-like peptide-1, which moderates appetite.

"Sustained high doses of the hormone levels several times higher than the body's typical production may cause the system to generate a reduced amount of its own natural GLP-1, and may also reduce responsiveness to its effects," explained Dr. Adam Collins, a dietetics expert.

"Withdrawal of this hormone supplement means hunger is uncontrolled, making overeating a significant risk."

A Lifelong Disease?

The NHS advise the jabs for people with weight-linked health risks, accompanied by recommended diet and exercise modifications.

Professionals contend that, given the likelihood of weight regain, the therapy should be considered long-term.

This opinion is echoed by drug manufacturers, who state that the results "emphasize the chronic nature of obesity," comparing it to managing conditions like diabetes.

Patient Accounts

Users who have come off the jabs report a sudden resurgence of appetite.

"I experienced a switch that goes on and you're instantly ravenous," recalled one woman.

The struggle is compounded if individuals have not established lasting dietary or behavioural modifications during treatment.

Widespread Interest

Survey data show that a significant number of adults in the UK have used weight-loss jabs in the last 12 months, with demand being substantial.

• Use is more common among women than men.
• The middle-aged age group shows the greatest usage rates.
• A large proportion obtain the drugs through private prescriptions rather than public health services.

Ultimately, researchers caution that while GLP-1 drugs are powerful agents for shedding pounds, they are not a permanent fix and maintained weight loss likely depends on ongoing lifestyle changes.